Health Care
Biotech & Healthcare Webinar Recap – Antisense Therapeutics (ASX:ANP)
In this one of a four-part webinar recap, Mark Diamond, Managing Director & CEO of Antisense Therapeutics Limited (ASX:ANP) presented on the company’s latest announcements and updates, while answering some questions during the Q&A session at the end.
StockPal hosted its first Biotech & Healthcare webinar on 4 August for four ASX- and NASDAQ-listed health care companies. This webinar is co-organised with Rawson Lewis.
Download the full presentation here: https://www.antisense.com.au/presentations/
Subscribe to our mailing list to stay up-to-date with future events and company updates.
The companies that participated were as follows:
Recce Pharmaceuticals (ASX:RCE) – James Graham (Executive Director) – https://www.recce.com.au/
Antisense Therapeutics (ASX:ANP) – Mark Diamond (Managing Director) – https://www.antisense.com.au/
Medlab (ASX:MDC) – Sean Hall (Chief Executive Officer, MD) – https://www.medlab.co/
Aptorum Group (NASDAQ:APM) – Darren Lui (President and Executive Director) – https://www.aptorumgroup.com/